Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

When drugs collide ….

Posted on July 15th, 2016 by in Pharmacovigilance

Pharmaceutical companies increasingly are adopting “proactive pharmacovigilance” and other strategies to help ensure the safety of a new entity as early as possible in the discovery/development process. Continue reading “When drugs collide ….” »

How Better Data is Reducing Drug Development Costs

Posted on July 1st, 2016 by in Pharma R&D

We’ve all heard how expensive it is to bring a drug to market. Depending on who you ask, the costs have risen somewhere between USD 1.6 and 2.6 billion.  Continue reading “How Better Data is Reducing Drug Development Costs” »

A Holistic Cure for the Pharmaceutical Industry’s Ailments

Posted on June 17th, 2016 by in Pharma R&D

Since the turn of the century, the pharmaceutical industry has seen dramatic changes, including dwindling drug pipelines, looming patent expirations and rising costs. Continue reading “A Holistic Cure for the Pharmaceutical Industry’s Ailments” »

Reducing the Risk of Late-Stage Failure with In Silico Modeling

Posted on June 15th, 2016 by in Pharma R&D

In silico modeling is arguably one of the hottest trends in life sciences R&D today. We know that bringing drug discovery to the desktop impacts cost. Continue reading “Reducing the Risk of Late-Stage Failure with In Silico Modeling” »

  1. 1
  2. 2